SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-21-003133
Filing Date
2021-07-28
Accepted
2021-07-28 14:24:57
Documents
9
Period of Report
2021-07-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K xenetic_8k.htm 8-K 39554
2 FORM OF UNREGISTERED PRE-FUNDED WARRANT xenetic_ex0401.htm EX-4.1 101910
3 FORM OF UNREGISTERED COMMON WARRANT xenetic_ex0402.htm EX-4.2 101947
4 FORM OF PIPE SECURITIES PURCHASE AGREEMENT xenetic_ex1001.htm EX-10.1 245407
5 REGISTRATION RIGHTS AGREEMENT xenetic_ex1002.htm EX-10.2 144287
6 ENGAGEMENT LETTER xenetic_ex1003.htm EX-10.3 56789
7 PRESS RELEASE xenetic_ex9901.htm EX-99.1 13285
8 GRAPHIC logo.jpg GRAPHIC 3390
9 GRAPHIC wainrightheader.jpg GRAPHIC 7456
  Complete submission text file 0001683168-21-003133.txt   719759
Mailing Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701
Business Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37937 | Film No.: 211121905
SIC: 2834 Pharmaceutical Preparations